Algorae Pharmaceuticals (ASX:1AI) Dividend Payout Ratio : 0.00 (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Algorae Pharmaceuticals Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Algorae Pharmaceuticals's Dividend Payout Ratio for the months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Algorae Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:

ASX:1AI's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.48
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-12-12), the Dividend Yield % of Algorae Pharmaceuticals is 0.00%.

Algorae Pharmaceuticals's Dividends per Share for the months ended in Dec. 2023 was A$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Algorae Pharmaceuticals Dividend Payout Ratio Historical Data

The historical data trend for Algorae Pharmaceuticals's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algorae Pharmaceuticals Dividend Payout Ratio Chart

Algorae Pharmaceuticals Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Dividend Payout Ratio

Get a 7-Day Free Trial

Algorae Pharmaceuticals Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Algorae Pharmaceuticals's Dividend Payout Ratio

For the Biotechnology subindustry, Algorae Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Algorae Pharmaceuticals's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Algorae Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Algorae Pharmaceuticals's Dividend Payout Ratio falls into.

Algorae Pharmaceuticals Dividend Payout Ratio Calculation

Algorae Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Jun. 2024 )	/	EPS without NRI (A: Jun. 2024 )
	=	0	/	-0.001
	=	N/A

Algorae Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0	/	-0.001
	=	N/A

Algorae Pharmaceuticals (ASX:1AI) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Algorae Pharmaceuticals Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Algorae Pharmaceuticals's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Algorae Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algorae Pharmaceuticals Ltd (ASX:1AI) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

LVCLF:USA LHI0:Germany

Address

525 Collins Street, Level 23, Rialto South Tower, Melbourne, VIC, AUS, 3000

Website

https://www.algoraepharma.com

Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for under met medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. The products of the company comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The company is conceptualized to be a potential treatment for dementia, including Alzheimer's disease, NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.

Algorae Pharmaceuticals Headlines

No Headlines